Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000078003-21-000035
Filing Date
2021-02-16
Accepted
2021-02-12 18:37:42
Documents
2
Group Members
PFIZER VENTURES (US) LLC

Document Format Files

Seq Description Document Type Size
1 4D MOLECULAR SC 13G a4dm_13gx2x21.htm SC 13G 58659
2 EX-99.1 a4dm_sc13gxexx99x12021.htm EX-99.1 6974
  Complete submission text file 0000078003-21-000035.txt   67382
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Subject) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91921 | Film No.: 21630835
SIC: 2836 Biological Products, (No Diagnostic Substances)